Uncommon Immune-Mediated Disease 10) Polymyositis

1. Etiology

  • ๋Œ€๋ถ€๋ถ„ primaryํ•œ ์ž๊ฐ€๋ฉด์—ญ์งˆํ™˜
    • ์ข…์–‘์— ์˜ํ•ด ์†๋ฐœํ•˜๊ธฐ๋„ ํ•จ: Paraneoplastic immune-mediated myositis (PNS; paraneoplastic syndrome)
    • ํŠนํžˆ ==lymphoma ๊ฑธ๋ฆฐ Boxers==
  • ๋ช…ํ™•ํ•œ ๊ธฐ์ „์€ ๋ฐํ˜€์ง€์ง€ ์•Š์•˜์œผ๋‚˜, Type โ…ฃ delayed type - cytotoxic T cells ๊ด€๋ จ์œผ๋กœ ํŒŒ์•….
    • SLE๋Š” T suppressor cell, PM์€ cytotosic T cell
  • IMPA์™€ ํ•จ๊ป˜ ๋ฐœ๋ณ‘ ๊ฐ€๋Šฅ โ†’ โ€œcanine polyarthritis/myositis syndromeโ€

2. Clinical signs

Clinical signs (๊ทผ์œก ๊ด€๋ จ!!)

  • ์šด๋™ ๊ธฐ๋Šฅ ๊ฐ์†Œ, weakness
  • ๋ณดํ–‰ ์ด์ƒ
  • ๊ทผ์œก ํ†ต์ฆ
  • ์‹์š• ๋ถ€์ง„, ํ˜€ ์œ„์ถ•(์ž˜ ๋ชป ๋ดค์ง€๋งŒ, ํ˜€๋„ ๊ทผ์œก์ด๋‹ˆ๊นŒ..)
  • ๊ฑฐ๋Œ€์‹๋„
  • ๋‹ค๋ฐœ์„ฑ ๊ทผ์—ผ์ธ ๋งŒํผ, ์ €์ž‘๊ทผ ๊ทผ์—ผ๋„ ํฌํ•จ๋˜์–ด ๊ฐ™์ด ๋ฐœ์ƒํ•  ์ˆ˜ ์žˆ์Œ.

3. Diagnosis

  • CK level์ด ๋„ˆ๋ฌด ์ฆ๊ฐ€? ๊ทผ์œก ๊ด€๋ จ ๋ฌธ์ œ์ž„์„ ์˜์‹ฌ. - ํŠนํžˆ polymyositis๋ฅผ ์šฐ์„ ์ ์œผ๋กœ ์˜์‹ฌํ•ด๋ณด์ž.
  • ๊ฐ์—ผ์งˆํ™˜์˜ ruleout์ด ์ค‘์š”ํ•จ. (Eosinophil์ด๋ฉด ํŠนํžˆ ๊ฐ์—ผ์ฒด ๊ฐ€๋Šฅ์„ฑ..)
  • Boxer lymphoma์™€ ๋‹ค๋ฐœ์„ฑ ๊ทผ์—ผ์€ ๋ฐ€์ ‘ํ•œ ์—ฐ๊ด€์ด ์žˆ๋‹ค.
  • Treatment : ์ €์ž‘๊ทผ์—ผ๊ณผ ๋น„์Šทํ•จ
  • Prognosis : good